Psychedelics & MDMA as Potential Supplements to Treat High-Functioning Autism & Asperger’s Syndrome
A graduate student of clinical psychology and a research associate and co-facilitator for the Harbor-UCLA cancer anxiety trial with psilocybin, Alicia Danforth provided an overview of the research from the late 1950s through the early 1970s on the use of LSD and psilocybin in the treatment of severe autism in children. She also discussed the potential use of MDMA-assisted therapy as a supplement to treatment for individuals with high-functioning autism and Asperger’s syndrome.
This video is from Psychedelic Science in the 21st Century, a conference taking in place in San Jose, California on April 15-18, 2010. The conference was organized by the Multidisciplinary Association for Psychedelic Studies (MAPS) in collaboration with the Heffter Research Institute, the Council on Spiritual Practices, and the Beckley Foundation.
Medical doctors, nurses, psychiatrists, psychologists, social workers, and other health professionals can earn Continuing Medical Education/Continuing Education (CME/CE) credits by viewing these videos through the Spiritual Competency Resource Center (SCRC) at spiritualcompetency.com.
This video was produced by Teal Sievers of Living Dream Films (livingdreamfilms.com).
To learn more about MAPS or to support our work, visit maps.org.